The Max Foundation (Max) has announced that three patients have started treatment for HER2 negative/HR positive advanced breast cancer (ABC) including CDK4/6 inhibitor therapy in Mozambique through its Max Access Solutions programme.
Trending
- Antimicrobial resistance deadlier than HIV, TB, malaria—NCDC
- Gene editing more efficient than traditional crop, animal breeding – Expert
- Combating malaria requires innovation, youth-driven ideas – Pharmaceutical Coy
- N5m govt gift sparks crisis in NUJ Kano Correspondents’ Chapel
- EFCC probes Kyari, 13 others over alleged financial misconduct at NNPCL
- Double Galadimas: Kano Emirate divided as Sanusi, Bayero make rival appointments
- “Call your family to order”, Atiku warns President Tinubu
- Grand Theft Auto VI release postponed to May 2026
